ARTICLE | Distillery Therapeutics
Cancer
May 1, 2018 11:29 PM UTC
Cell culture and mouse studies identified a TF-binding immunoconjugate that could help treat triple-negative breast cancer (TNBC). The immunoconjugate consists of a factor VII peptide light chain fuse...
BCIQ Company Profiles
BCIQ Target Profiles